It is also overexpressed in Sezary syndrome (SS), a rare, aggressive CD4+ cutaneous T-cell lymphoma (Booken et al., 2008). This evidence concerns the gene CD4 and primary cutaneous T-cell non-Hodgkin lymphoma.